OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.

about

Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways.Antrodia cinnamomea boosts the anti-tumor activity of sorafenib in xenograft models of human hepatocellular carcinoma

P2860

Q52682335-073900A3-6DE6-4F6C-95B5-CCD7A4D70CE3 Q58701446-F42A097B-480C-40FE-A086-0816B37DA3D0

P2860

OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.

Item

http://www.wikidata.org/entity/Q42362014

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@en

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@nl

type

Item

label

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@en

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@nl

prefLabel

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@en

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@nl

P1476

OSU-2S/Sorafenib Synergistic A ...... rcinoma: The Role of PKCδ/p53.

@en

P2093

Taleb H Al-Tel

http://www.w3.org/2001/XMLSchema#string

P2860

FTY720 story. Its discovery and the following accelerated development of sphingosine 1-phosphate receptor agonists as immunomodulators based on reverse pharmacology

Sorafenib in advanced hepatocellular carcinoma

Sorafenib in combination with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis

Regulation of cell apoptosis by protein kinase c delta

Quantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry.

Nuclear import of PKCdelta is required for apoptosis: identification of a novel nuclear import sequence.

Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.

Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.

Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis.

Comparative dosing and efficacy of sorafenib in hepatocellular cancer patients with varying liver dysfunction

P304

463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2016.00463

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jui-Hsiang Hung

Hany A. Omar

Mai F. Tolba

P577

2016-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27965580

http://www.w3.org/2001/XMLSchema#string

P932

5127788

http://www.w3.org/2001/XMLSchema#string

OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.

about

P2860

P2860

OSU-2S/Sorafenib Synergistic Antitumor Combination against Hepatocellular Carcinoma: The Role of PKCδ/p53.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932